Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-004249
Filing Date
2021-01-20
Accepted
2021-01-20 16:00:13
Documents
1
Period of Report
2021-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4268
  Complete submission text file 0001209191-21-004249.txt   5729
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Issuer) CIK: 0001654151 (see all company filings)

EIN.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DECIPHERA PHARMACEUTICALS, INC. 200 SMITH STREET WALTHAM MA 02451
Business Address
Friedman Franklin Stuart (Reporting) CIK: 0001794351 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38219 | Film No.: 21538749